Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seizure, Partial Onset”

215 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 215 results

Early research (Phase 1)Looking for participantsNCT07233239
What this trial is testing

Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

Who this might be right for
Focal Seizures
Jazz Pharmaceuticals 100
Large-scale testing (Phase 3)Study completedNCT00433667
What this trial is testing

The Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Who this might be right for
EpilepsyEpilepsy, FocalSeizure Disorder+2 more
SK Life Science, Inc. 563
Large-scale testing (Phase 3)Study completedNCT00150800
What this trial is testing

This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment

Who this might be right for
Epilepsy
UCB PHARMA Inc. (US) 668
Not applicableStudy completedNCT06960811
What this trial is testing

Epileptic Psychoses and Their Link With Ictal Emotions and Consciousness

Who this might be right for
Epilepsy With Partial Onset Seizures With or Without Secondary GeneralizationPsychosesEpilepsy, Generalized
Central Hospital, Nancy, France 117
Post-approval studies (Phase 4)Study completedNCT00266604
What this trial is testing

Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy

Who this might be right for
EpilepsySeizuresEpilepsies, Partial+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 409
Early research (Phase 1)Study completedNCT04903314
What this trial is testing

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

Who this might be right for
Partial Epilepsy
SK Life Science, Inc. 26
Large-scale testing (Phase 3)Study completedNCT01261325
What this trial is testing

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 768
Testing effectiveness (Phase 2)Ended earlyNCT04153175
What this trial is testing

Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization

Who this might be right for
Refractory Epilepsy
Cerebral Therapeutics LLC 30
Not applicableStudy completedNCT04252846
What this trial is testing

Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

Who this might be right for
Idiopathic Generalized EpilepsyPartial Onset SeizuresGeneralised Tonic-Clonic Seizures
Eisai Limited 191
Not applicableLooking for participantsNCT06657378
What this trial is testing

Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures

Who this might be right for
Partial-Onset SeizuresPrimary Generalized Tonic-clonic Seizures
Eisai Co., Ltd. 110
Large-scale testing (Phase 3)Study completedNCT03201900
What this trial is testing

Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study)

Who this might be right for
Partial Onset Seizures
Eisai Co., Ltd. 91
Large-scale testing (Phase 3)Study completedNCT00530855
What this trial is testing

Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 322
Large-scale testing (Phase 3)Study completedNCT00615615
What this trial is testing

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 216
Not applicableStudy completedNCT02736162
What this trial is testing

Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

Who this might be right for
EpilepsyPartial-Onset SeizuresPrimary Generalized Tonic-Clonic Seizures
Eisai Inc. 61
Large-scale testing (Phase 3)Study completedNCT00700310
What this trial is testing

Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Who this might be right for
Refractory Partial Seizures
Eisai Inc. 712
Early research (Phase 1)Study completedNCT00233012
What this trial is testing

The Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures

Who this might be right for
Seizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 16
Testing effectiveness (Phase 2)Study completedNCT06377930
What this trial is testing

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Who this might be right for
Focal Onset Seizures
Rapport Therapeutics Inc. 30
Not applicableUnknownNCT04737837
What this trial is testing

A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy

Who this might be right for
EpilepsyFocal-Onset Seizure
Jiangxi Qingfeng Pharmaceutical Co. Ltd. 200
Not applicableStudy completedNCT01830868
What this trial is testing

A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM)

Who this might be right for
Partial Onset Seizures
Eisai Inc. 104
Large-scale testing (Phase 3)Study completedNCT00113815
What this trial is testing

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Who this might be right for
Partial Seizure DisorderEpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 118
Next Page